But there are not nearly enough healers to dish out the (desperately required) medicine. Why?

“Mental health workforces are shrinking at a time the demand for mental health services is increasing,” says the news blog for Europe’s first psychedelic research centre Clerkenwell Health, just down the road from me in London. 

Dr Derek Tracy, medical director at West London NHS Trust, told Sky News earlier this month that he has never seen such a high demand for access to mental health treatment. “It's as busy as I've ever seen in my career. Numbers are up across all age groups and in all types of presentations, in London and nationally.”

March 2021 figures claimed a quarter of adults reported ‘clinically significant psychological distress’ that month, up from just over a fifth before the C-19 pandemic. 

So one in four of us are suffering from… ‘clinically significant psychological distress’. Suicides are up again since 2018. In May 2022 the number of under-18s referred to emergency mental health services went up 37% on the previous year, a record high. Depression and anxiety are the number one reason for taking time off work.

“There are not enough therapists to deliver these treatments”

This while corks pop on bottles of Nyetimber as the UK is declared “world leading” in the innovative treatment research field.

Back on Clerkenwell Health’s blog, “Developing new drugs has attracted significant commercial interest. But the delivery aspects of these treatments are yet to receive the same attention. There are more than 150 psychedelic drug developers in the market. Patients’ demand for psychedelics is also increasing.”

Clerkenwell Health’s stark conclusion? “There are not enough therapists to deliver these treatments.”

I’d respond: that’s because there are too many barriers to becoming qualified.

This week Vital students heard from lawyer Courtney Barnes, who detailled Oregon’s facilitator license training requirement that are not dissimilar to its own syllabus. Clerkenwell Health’s own psychedelic therapy program requires accredited health professional (AHP) status for entry. Which puts it beyond my means, for example. That requires a degree in occupational therapy at least, or better still being a clinical psychologist, which involves a decade or so of grind that I’ve been told by those who know for sure is not worth me trying in my mid-40s. Psychotherapist training is three to six years according to the UK Council for Psychotherapy. 

I wonder how long the list would really be of qualified individuals, who have experience with psychedelics, and have long harboured a compulsion towards a very different psychological approach? How do they feel about the commute to central London?

Who otherwise has the time or the money to retrain? I’ve worked with graduates in £80K of debt who want to be superstar fashion stylists, not spend their days under fluorescent light talking to long-term alcoholics about their visuals. Experts from Stanislav Grof to Dr Rick Strassman implore upon prospects how demanding psychedelic therapy can be.

This is before we talk about the 28% of AHPs who quit due to burnout, the 16% who want to leave the sector entirely, the 43% actively looking for a new job, or the third who cite low pay and overwork as the main issues.

“Developing new drugs has attracted significant commercial interest. But the delivery aspects of these treatments are yet to receive the same attention”

100,000 vacancies in the NHS lie unfilled while expensive and life-consuming qualifications that were once unnecessary – my mother worked as a midwife, and the ward sister at Dick Whittington Hospital A&E here in London with no university education – stand right in the way of anyone compelled to join the sector. Anecdotally: a friend who’s worked at a high level in nursing for 12 years, including on the COVID-19 ward, has to undertake an MSc (in… nursing) before she can go up a pay grade and become a senior nurse. Granted there may be one or two useful things she picks up during it, but compared to 12 years on the job will it be worth the time and the debt? Especially given the demand for senior nurses?

Full psychopomp status via the Clerkenwell Health program lasts only three months and is free, incidentally. To accredited healthcare professionals.

Embers of hope burn, certainly with outspoken, heritage foundations like Beckley emerging into the C-suite conversation and the fast-tracking of the MAPS PTSD programme. Though no wonder unofficial psychedelic mental health services thrive. While these may cater well to the slightly-unhealthy normals, who Grof to David Nutt say can benefit immediately from psychedelic experience alone, they cannot expect to hold back the tide of trauma and addiction. And as almost everyone connected to the issues –except the gatekeepers – agrees, the current set-up certainly can’t either.